This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Xianfeng Sun: Innovator in Pharmaceutical Chemistry
Introduction
Xianfeng Sun is a notable inventor based in Guilderland, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target fatty acid binding proteins.
Latest Patents
Xianfeng Sun holds a patent for "Substituted quinoxalines as inhibitors of fatty acid binding protein." This invention relates to novel quinoxaline compounds that serve as inhibitors of Fatty Acid Binding Protein (FABP). The pharmaceutical compositions comprising these quinoxaline compounds are aimed at treating or preventing various health issues, including cardiovascular diseases, metabolic disorders, obesity, diabetes, dyslipidemia, and complications related to diabetes.
Career Highlights
Xianfeng Sun is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work focuses on innovative solutions that address critical health challenges through advanced pharmaceutical research.
Collaborations
Xianfeng has collaborated with esteemed colleagues, including Clifford Cheng and Gerald Wayne Shipps, Jr. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Xianfeng Sun's contributions to pharmaceutical chemistry highlight his role as an innovator in the field. His work on quinoxaline compounds demonstrates the potential for new treatments for serious health conditions.